CIMT annual meetings

CIP coorganizes scientific sessions at the CIMT Annual Meeting


CIMT 2018

This year, CIP will organize a plenary session and a short talk session.
For more information, please see the CIMT 2018 meeting program 


Third CRI-CIMT-EATI-AACR conference, Sept 2017, Mainz

CIP presented a series of posters on all activities of the working group


CIMT 2017 Anniversary symposium, May 2017

Immunoguiding Seminar Speakers: Javier Romero Ros (Academic Medical Center, Amsterdam), Sven Brandau (University Hospital Essen), Tanja de Gruijl (VU University Medical Center Amsterdam), Angela M. Krackhardt (Technical University Munich)


CIMT 2016

Day 3 - May 12,  2016 - Plenary session 5: Novel Technologies for Immune Assessment
Timothy Tree King's College (London, the UK)
Measuring regulatory T cell phenotype and function in human health and disease
Sine Reker Hadrup Technical University of Denmark (Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells
Giuliano Elia, Philochem (Otelfingen, Switzerland)
A phase III trial of the intralesional application of L19IL2/L19TNF in stage IIIB/C melanoma patients

Day 3 - May 12, Short Talk session VI:Immunomonitoring
 Amalie Kai Bentzen Technical University of Denmark
(Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells using DNA barcode-labeled
peptide-Major Histocompatibility Complex I multimers
Coco de Koning UMC (Utrecht, The Netherlands)
CD4+ T-cell immunomonitoring after hematopoietic cell transplantation:
identifying patients at risk for virus-predicted adverse outcomes
Gabriele Niedermann University Clinics (Freiburg, Germany)
Noninvasive ImmunoPET imaging of the PD-1/PD-L1 checkpoint in naïve and irradiated tumor-bearing mice
Paulo Rodrigues-Santos Faculdade de Medicina da Universidade de Coimbra (Coimbra, Portugal)
Immune monitoring of natural killer cells in chronic myeloid leukemia:
split anergy status depend on tyrosine kinase inhibitor therapy
Julien Schmidt Ludwig Center (Lausanne,
Isolation and analysis of tumor-specific CD8 and CD4 T cells with high affinity, reversible pMHC multimers"

CIMT 2015

Day 1 - May 11, 2015 - Symposium on Computational Tools for Biomarker Discovery
Ryan Brinkman British Columbia Cancer Agency (Vancouver BC, Canada)
Computational tools for flow cytometry and how well they work
Sylvia Janetzki ZellNet Consulting (Fort Lee, NJ)
The age of computing: challenges in data analysis for functional immune assays
Tomas Kalina Charles University (Prague, Czech Rpublic)
How standardization of flow cytometry facilitates computational analyses - EuroFlow experience
Pratip Chattopadhyay National Institutes of Health (Bethesda, Maryland) The next dimension in single cell cytometry: integrating computational tools for more powerful experiments
Pia Kvistborg (National Cancer Institute Amsterdam The Netherlands) and Marij Welters (LUMC, Leiden, The Netherlands) Update on CIP activities and closing words


Day 3 - May 13, 2015 Short talk session VI / Immunomonitoring
Katharina Epp Johannes Gutenberg-Universität (Mainz, Germany)
Functionally impaired GPI-anchor negative regulatory T cells strongly correlate with acute Graft versus Host Disease after Alemtuzumab-based conditioning regimen
Keisuke Fujii University Graduate School of Medicine (Mie, Japan)
Development of a novel rapid and sensitive method for detection of cellular immune responses and selection of immunogenic peptides encoded by mutated genes
Jan Dörrie University Hospital (Erlangen, Germany)
Electroporation of CD8+ effector T cells with antigen is suitable to test their reactivity to tumor antigens
Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Prognostic impact of circulating plasmacytoid dendritic cells and immunosuppressive subsets in breast cancer
Sofie Ramskov Andersen Technical University/National Veterinary Institute (Copenhagen, Denmark)
Identification of novel T cell epitopes in breast cancer

CIMT 2014

Day 1 - May 6, 2014 - CIP Breakout Session
Steffen Walter immatics biotechnologies GmbH (Tübingen, Germany) MDSC Phenotyping Proficiency Panel
Ruth Challis University of Southampton (Southampton, United Kingdom)
Preliminary results from the NK harmonization panel
Henrik Pedersen Immudex (Copenhagen, Denmark) MHC Multimer Proficiency Panel 2014:
The data obtained prove high reproducibility of the MHC Multimer assay
Nicole Bidmon University Medical Center Mainz (Mainz, Germany)
TCR-engineered reference samples (TERS) to control T-cell assay performance –towards an immune-control kit
Saskia Santegoets Leiden University Medical Center (Leiden, The Netherlands)
Results of the CIP workshop on the detection and functional testing of (antigen-specific) regulatory T cells
Pia Kvistborg Netherlands Cancer Institute (Amsterdam, The Netherlands)
Automated analysis of flow cytometry data – bridging two world
Cliburn Chan Duke University (Durham, USA)
Managing multi-center flow cytometry data for cancer immune monitoring

Day 2 - May 7, 2014 - Plenary Session 4 / Immunoguiding
Eric Vivier Centre d´Immunologie (Marseille, France)
Natural killer cells and innate lymphoid cells
Pedro Romero Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Monitoring tumor antigen-specific T-cell responses

Day 3 - May 8, 2014 - Short Talk Session V / Immunomonitoring
Petra Baumgärtner Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Survival of melanoma patients correlating with DTH skin reactions and CD8 T cell/ Treg ratios in PBMC after vaccinations with CpG & peptides
Julia Fischer Institute for Virology and Immunobiology (Würzburg, Germany)
Resetting circulating CD8 T-cells to a tissue-like status permits sensitive detection of their responses to virus- and tumor-associated antigens
Michael Hebeisen  Lausanne University Hospital (Lausanne, Switzerland)
Reversible NTAmer technology enables rapid and direct detection of monomeric TCRpMHC kinetics at the cell surface and predicts tumor-specific T cell responsiveness
Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Presence of circulating Her-2-reactive CD8 T-cells is associated with lower frequency of MDSCs and better survival in elderly breast cancer patients
Oliver Lantz  Institut Curie and INSERM (Paris, France)
High numbers of differentiated effector CD4 T cells are found in cancer patients and correlate with clinical response after neo-adjuvant therapy of breast cancer